All News

Researchers examined the suicide rates of NCAA student-athletes from 2002 to 2022.

Health care providers must listen to patients who voice their experiences with post–COVID-19 condition symptoms. Only then can a clearer picture of the condition emerge for the millions of patients who have the near-invisible disease.

Researchers analyzed the efficacy of continuous glucose monitoring as the standard of care for diabetes management in an inpatient setting.

Findings from the FAMS-T1D study show that structured goal-setting and achievement significantly enhance self-efficacy and self-care in emerging adults.

In case you missed it, this week we had news about joint business ventures in pharmacy, an uptick in fentanyl seizures across the US, sunscreen safety, and more.

Check out important updates from the FDA for the week of May 13.

Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”

Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.

Test your pharmacy news knowledge with our weekly quiz.

Over half of the money is set to assist the overall effort to stop the virus, while the remaining funds will go to dairy farms affected by the bird flu outbreak.

Efsitora (efsitora alfa) from Eli Lilly met its primary endpoint of non-inferior A1C reduction compared to insulin degludec and insulin glargine in 2 phase 3 studies.

Chris Schaffner, PharmD, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, sat down with Drug Topics to discuss his joint business venture.

Test your knowledge of food allergies.

Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.

The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.

Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.

Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.

Dynavax plans to meet with the FDA to discuss how the company can provide additional data to support the approval of its 4-dose Heplisav-B regimen and expand protection for adults with end-stage renal disease (ESRD) on hemodialysis.

Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?

For Melanoma and Skin Cancer Awareness Month, Drug Topics sat down with Colleen McCabe, PharmD, BCOP, to glean clinical insights into promoting skin cancer awareness in the community pharmacy.

During World Asthma Day on May 7, advocacy groups for asthma awareness addressed the need for better worldwide education.

Researchers aimed to better understand the intricacies of local allergic rhinitis and how it differs from allergic rhinitis.

Study results suggest a nationwide increase in the supply and availability of illicitly manufactured fentanyl, with pills becoming more dominant across the ever-shifting US fentanyl market.

In Germany, data live in the cloud, patients can fill prescriptions at any pharmacy, and the wholesale price of semaglutide (Ozempic) is a fraction of the cost.

In case you missed it, this week we had news about pharmacy issues in the election spotlight, advancements in psychedelic therapeutics, prior authorization, and more.

Check out important updates from the FDA for the week of May 6.

The company, which operates 140 care sites across the country, was forced to shut down health systems earlier this week because of the disruption.

Test your pharmacy news knowledge with our weekly quiz.